Amyloidogenic Peptides in Human Blood - Health Alliance Australia

Amyloidogenic Peptides in Human Blood

To whom it may concern,

RE: Concerning implications of latest research on COVID19 for public health.

Preliminary research by eminent neuroscientist, Dr Kevin McCairn has found that exposure to SARS-COV-2 whether by infection or injection can lead to a systemic amyloid type disorder that is directly related to rapid increases in the incidence of neurological diseases, cancers and turbo cancers, heart diseases, etc.. and potentially increased miscarriages, still births, and infertility.

Embalmers have found the presence of unusual white, fibrous clots and these clots were analyzed by Dr Kevin McCairn using combination of gross morphological inspection, cryosection histology, fluorescent staining, scanning electron microscopy (SEM), elemental analysis (EDX), real-time PCR, Raman spectroscopy, and Real-Time Quaking-Induced Conversion (RT-QuIC) and the samples were examined for biochemical and ultrastructural features associated with amyloidogenic and protease-resistant fibrin formation.

The clot samples were found to exhibit hallmarks of abnormal protein aggregation consistent with pathological fibrin remodeling, including enhanced autofluorescence, beta-sheet rich domains, dense fibrillar ultrastructure, and spectral anomalies.

The full scientific report can be found

https://kevinwmccairnphd282302.substack.com/p/cadaver-calamari-amyloidogenic-fibrin

A systemic amyloid type disorder is considered on the hospital scale one of the most serious conditions that you can develop. There is very little in the way of treatments and as people progress through the illness, the light chain amyloids penetrate into their organs and the organs shut down because they become gummed up with this amyloidogenic peptide.

As a result of this research, Dr Kevin McCairn is confident that most blood products post COVID are contaminated with misfolded fibrin. His laboratory has offered testing to detect amyloid burden in blood samples which can be posted to him from anywhere in the world and he has found that 90% of the blood tested has the spike protein-induced amyloidogenic peptides. 

This is very concerning because after the initial seeding there is an amyloidogenic cascade that leads to the manifestation of disease as we understand it. It is not just the immune system dysregulation at this point, but the peptide itself is causing this build up of toxic peptides in the body.

When an infectious prion comes into contact with a healthy one, it causes the healthy protein to mis-fold and become infectious too. Once the process starts, it is almost impossible to stop and over time, if these prions cross the blood brain barriet, they create holes in the brain tissue, leading to a sponge-like appearance, hence the term spongiform encephalopathy.

Dr Kevin McCairn did a detailed interview with Health Alliance Australia in May 2025
https://www.youtube.com/watch?v=w3RjTGpEVWs

The full interview can be found

https://rumble.com/v6sd87z-warning-global-amyloidogenic-health-disaster-with-dr-kevin-mccairn.html

Call to Action

Immediate action needs to be taken to stop all covid19 vaccination, screen all blood products for the presence of amyloidogenic peptides and fund research which should include counter measures like peptide fusion inhibitors and how blood types, such as K26R blood are less susceptible to covid infection.

Scientists, doctors, public health officials, politicians, in particular need to be briefed on this important finding, and the implications that include increased diseased burden, excess deaths, declining births due to this novel disease pathway.

Conclusion

The ramifications of contaminated blood supply full of amyloidogenic peptides is potentially a civilization ending event and as per the interview linked above, excess death is also high in younger aged groups. In simple terms, SARS-cov-2 hijacks the clotting system producing amyloidogenic fibrin that damage blood vessels and drives an inflammatory response, also leading to collagen degradation. Every covid infection or injection, increases the risk of long covid, and death.

This issue is only going to worsen over time, especially if left unaddressed.

Related studies include:

Fibrin drives thromboinflammation and neuropathology in COVID-19

https://www.nature.com/articles/s41586-024-07873-4#:~:text=Fibrin%20promotes%20neuroinflammation%20and%20neuronal,lungs%20independently%20of%20active%20infection

Quay, Steven Carl (2024) “The thrombo-inflammation and neuropathology sequence motifs of the SARS-CoV-2 spike protein appear to have been engineered into the virus”

https://zenodo.org/records/14559752

Aksenova, A. Y., Ershova, E. S., and Pavlov, A. V. (2022). The increased amyloidogenicity of Spike RBD and pH-dependent binding to ACE2 may contribute to the transmissibility and pathogenic properties of SARS-CoV-2 Omicron as suggested by in silico study. International Journal of Molecular Sciences, 23(21), 13502.

https://doi.org/10.3390/ijms232113502

Cao, S., et al. (2023). Spike protein fragments promote Alzheimer’s amyloidogenesis. ACS Applied Materials & Interfaces, 15(34), 40317–40329.

https://doi.org/10.1021/acsami.3c09815

Freeborn, J. (2022, May 26). Misfolded spike protein could explain complicated COVID-19 symptoms. Medical News Today. https://www.medicalnewstoday.com/articles/misfolded-spike-protein-could-explain-complicated-covid-19-symptoms

Idrees, D., & Kumar, V. (2021). SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochemical and Biophysical Research Communications, 554, 94–98.

https://doi.org/10.1016/j.bbrc.2021.03.100

Ma, G., et al. (2022). SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy. Cell Discovery, 8, 99.

https://doi.org/10.1038/s41421-022-00458-3

Nahalka, J. (2024). 1-L transcription of SARS-CoV-2 Spike Protein S1 Subunit. International Journal of Molecular Sciences, 25(8), 4440.

https://doi.org/10.3390/ijms25084440

Nyström, S. (2022). Amyloidogenesis of SARS-CoV-2 Spike protein. Journal of the American Chemical Society, 144, 8945–8950.

https://doi.org/10.1021/jacs.2c03925

Petrlova, J., et al. (2022). SARS-CoV-2 spike protein aggregation is triggered by bacterial lipopolysaccharide. FEBS Letters, 596, 2566–2575.

https://doi.org/10.1002/1873-3468.14490

Petruk, G., et al. (2020). SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. Journal of Molecular Cell Biology, 12, 916–932.

https://doi.org/10.1093/jmcb/mjaa067

The file is available to be downloaded below for distribution

To top